Key points: 

• The fireside chat brought together leaders from regulatory agencies, industry and patient organisations to discuss how Europe can remain competitive and responsive amid rapid scientific and technological change. Panellists discussed the need for greater harmonisation and simplification of regulatory processes, especially for clinical trials, in order to attract research and manufacturing to Europe, while also emphasising the importance of leveraging digitalisation, AI and interoperable health data  
• Europe’s regulatory environment is complex but offers unique strengths through its networked approach and scientific rigour. Harmonisation and centralisation of processes, especially for clinical trials, are needed to enhance competitiveness and attract investment 

To read more key points and the session summary, login as a member or register for free using the links below.